Literature DB >> 9566592

Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development.

K Fujita1, K Shibayama, M Yamauchi, T Kato, M Ando, H Takahashi, K Iritani, N Yoshimoto, Y Nagata.   

Abstract

Oxidative stress is suggested as a significant causative factor for pathogenesis of neuronal degeneration on spinal cord of human ALS. We measured some enzymic activities implicating neuronal degeneration process, such as cytochrome c oxidase (CO), superoxide dismutase (SOD), and transglutaminase (TG) in spinal cord of an animal model of ALS, motor neuron degeneration (Mnd) mouse, a mutant that exhibits progressive degeneration of lower spinal neurons during developmental growth, and compared them with age-matched control C57BL/6 mice. CO activity in Mnd spinal cord decreased during early postnatal period, while SOD activity reduced in later stage. In Mnd tissue, TG activity in lumbar cord was increasing during early stage, but tended to decline in later period gradually. These biochemical alterations became evident prior to the appearance of clinical motor dysfunction which were observed in later stages of development in Mnd spinal cord.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566592     DOI: 10.1023/a:1022442904179

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  A filter paper assay for transamidating enzymes using radioactive amine substrates.

Authors:  L Lorand; L K Campbell-Wilkes; L Cooperstein
Journal:  Anal Biochem       Date:  1972-12       Impact factor: 3.365

Review 2.  Transglutaminases.

Authors:  J E Folk
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

Review 3.  Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death.

Authors:  L Fesus; V Thomazy
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

4.  Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease.

Authors:  C C Miller; B H Anderton
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

5.  Neurofilament distribution is altered in the Mnd (motor neuron degeneration) mouse.

Authors:  L M Callahan; E L Wylen; A Messer; J E Mazurkiewicz
Journal:  J Neuropathol Exp Neurol       Date:  1991-07       Impact factor: 3.685

6.  Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS).

Authors:  A Messer; J Plummer; P Maskin; J M Coffin; W N Frankel
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

7.  Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.

Authors:  A Mügge; J H Elwell; T E Peterson; D G Harrison
Journal:  Am J Physiol       Date:  1991-02

8.  Rapid and transient alterations in transglutaminase activity in rat superior cervical ganglia following denervation or axotomy.

Authors:  M Ando; S Kunii; T Tatematsu; Y Nagata
Journal:  Neurosci Res       Date:  1993-06       Impact factor: 3.304

9.  Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease.

Authors:  G Battaglioli; D L Martin; J Plummer; A Messer
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

10.  Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes.

Authors:  S Katoh; N Nakagawa; Y Yano; K Satoh; H Kohno; Y Ohkubo
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

View more
  3 in total

1.  Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity.

Authors:  K Fujita; T Kato; K Shibayama; H Imada; M Yamauchi; N Yoshimoto; E Miyachi; Y Nagata
Journal:  Neurochem Res       Date:  2006-07-28       Impact factor: 3.996

2.  Pathogenesis of axonal dystrophy and demyelination in alphaA-crystallin-expressing transgenic mice.

Authors:  A F Van Rijk; M A M Sweers; G F M Merkx; M Lammens; H Bloemendal
Journal:  Int J Exp Pathol       Date:  2003-04       Impact factor: 1.925

Review 3.  Polyamines: Functions, Metabolism, and Role in Human Disease Management.

Authors:  Narashans Alok Sagar; Swarnava Tarafdar; Surbhi Agarwal; Ayon Tarafdar; Sunil Sharma
Journal:  Med Sci (Basel)       Date:  2021-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.